I-Nuvigil (i-armodafinil) iyimvelaphi ye-Provigil (modafinil), apho abanye abantu abane-MS bathabatha ukulwa nokukhathala okuhlobene ne-MS .
Ubume beN Nuvigil
I-Nuvigil isetyenziselwa ukuphucula ukuvuka kubantu abadala ngokulala ngokugqithiseleyo okuxhomekeke kwezi zifo zontathu zonyango:
- ukuphazamiseka kokulala komzimba
- zonyango
- ukuguquka kwengxaki yomsebenzi
Oko kuthetha, ngamanye amaxesha kusetyenziswa ngaphandle-itytile (oko kuthetha ukuba akuyiyo i-FDA ivunyelwe) ukuphatha ukhathala kubantu abane-MS.
I-Nuvigil ayiyiyona inguqu ye-generic ye-Provigil kodwa ivela kwi-Provigil (isantya sokunene, ukuba ibe ngqo). Ukusebenzisa nje inxalenye yeli molecule eyenza i-Provigil kucatshangelwa ukuba yindlela yokufumana izibonelelo ezingaphezulu kunye nemiphumo emibini, ebonakala ihambelana nesondlo esisekhohlo.
Oko kuthethwa, i-Nuvigil inokubangela iindidi ezifanayo neziphumo ezinjenge-Provigil, eyona nto ibaluleke kakhulu ebomini okanye isifo esiyingozi. Enyanisweni, ukuba umntu uhlakulela nayiphi na impawu yokukhawuleza okanye ukuphendulwa komzimba, kubalulekile ukuba bafune uncedo oluphuthumayo ngokukhawuleza. Ezinye zeempawu ziquka:
- ukugqithisa kwesikhumba, ukuvuthwa, ukuxubha kunye / okanye ukukhangela kwesikhumba, izilonda emlonyeni
- ukuvuvukala ubuso, amehlo, imilomo, ulwimi, okanye umqala
- iingxaki zokugwinya okanye ukuphefumla
- umkhuhlane
- ukuvuvuka kwemilenze
- ukuphuka kwamehlo kunye / okanye umchamo omnyama
Ezinye iziphumo ezinobungozi ezingundoqo ezibandakanya iimpawu zengqondo ezifana nokuziva ecinezelekile, ukuxhalaba, ukufumana i-hallucinations, imania, okanye ukuziphatha kakubi, kunye / okanye ukucinga okuzibulala.
Iingxaki zeentliziyo zinokuthi zenzeke kwaye ziqinisekise ukuba uncedo lwonyango ngokukhawuleza. Izimpawu ezinokwenzeka ziquka intlungu yesifuba, ukuphefumula iingxaki, okanye ukubetha kwentliziyo engavamile.
Ngaphandle kwezi ziphumo ezibi kakhulu, i-Nuvigil ngokuqhelekileyo ibangele iziphumo zecala kubantu:
- intloko
- isicaphulelo
- ukungcola
- iingxaki zokulala
Kubalulekile ukuqhagamshelana nodokotela wakho ukuba unayo nayiphi na imiphumo engapheliyo okanye ephazamisayo, kuquka neye ngasentla okanye nayiphi na eyongezelelweyo.
Kwakhona uN Nuvigil angadibana kunye / okanye ukunciphisa ukusebenza kwamachiza athile afana neendlela zokulawula ukuzalwa kwezilwanyana (iipilisi, izibhengezo, iziplantshi, iifake, iindandatho kunye ne-IUDs). Oku kuthetha ukuba ibhinqa linokuba nelungelo lokukhulelwa ngelixa lithatha iNuvigil kunye nenyanga enye emva kokuyeka uNuvigil.
Ngenxa yobungakanani be-Nuvigil bokusebenzisana namanye amayeza, qi ni sekise ukuba ugqirha ugqirha wakho kuzo zonke iingxaki zakho zonyango kunye nawo onke amayeza owathathayo kuquka imiyalelo, izityalo, izongezelelo, iivithamini, kunye neyeza.
Amanye amabini amaphupha athwala ukuthetha. Isilinganisi sakho se-Nuvigil siya kuhluka kwi-doigil yakho ye-Provigil, ngoko uqaphele apha kwaye uyithathe kuphela njengoko ufundiswe ngugqirha wakho. Kwakhona, i-inshurensi yakho ingabikho i-Nuvigil kwinqanaba elifanayo njengoko lifunyenwe i-Provigil-lingaba liyeza elibi kakhulu.
Ngaba I-Nuvigil Isebenza?
Ubungqina bobunzululwazi obuxhasa ukusetyenziswa kukaNuvigil ekuphatheni kakuhle ukukhathala kwi-MS bubuthathaka kwaye buyinto engavumelekanga ngeli xesha. Oko kuthetha, inokusebenza kwabanye abantu, ngoko ugqirha wakho unokuncoma ukuba uzame, ngakumbi ukuba ezinye iindlela zokwelapha azisebenzi. Ekuphatheni ukukhathala, kudla ngokudibanisa ukungqinelana kwamanyathelo asebenzayo kuquka ukusetyenziswa, ukulala okufanelekileyo, ukujongana neminye imiba yempilo enokuchaphazela ukukhathala, kunye namayeza
ILizwi
Nangona i-Nuvigil ingabangela imiphumo emibi njengeentliziyo okanye iingxaki zengqondo, ngokuqhelekileyo zixhomekeke kakuhle kwaye zinokuba yindlela enokukhethayo kubantu abathile abanokukhathala okuhlobene ne-MS.
> Imithombo:
> Asano M, Finlayson ML. Uhlalutyo lwe-Meta lweentlobo ezahlukeneyo zolawulo lokunyamekela abantu abane-multiple sclerosis: ukuzivocavoca, imfundo kunye neyeza. IMult Scler Int. 2014; 2014: 798285.
> Braley TJ, Chervin RD. Ukukhathala kwi-sclerosis ezininzi: iindlela, ukuvavanya, kunye nonyango. Ukulala . 2010 uAgasti 1; 33 (8): 1061-67.
> Bruce J, Hancock L, uRoberg B, uBrown A, uHenkelman E, uLynch S. Impact ye-armodafinil kwi-clerosis kwi-sclerosis ezininzi: isifundo somqhubi se-crossover esingenangqondo. Cogn Behav Neurol . 2012 Sep; 25 (3): 107-14.
> Isikhokelo seMithi (ngo-Apreli 2015). Nuvigil.